Huntington National Bank Intercept Pharmaceuticals, Inc. Transaction History

Huntington National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 27, 2020	SELL	$48.35 - $118.68 $9,186 - $22,549	-190 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$57.36 - $124.1 $10,898 - $23,579	190 New	190 $24,000
Q3 2019 Nov 01, 2019	SELL	$58.69 - $80.46 $2,934 - $4,022	-50 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$57.01 - $118.75 $2,850 - $5,937	50	50 $3,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

Stay updated on Huntington National Bank with notifications on news.